Pharma for the Holidays

Altman explains clinical trials, relative risk, the FDA approval process, and pharmaceutical adverse events. As an advocate for The Alliance for Human Research Protection, Altman considers specific drugs and drug classes in the FDA’s Medwatch database.

In this “Investigating Innocence” seminar video, Attorney Keith Altman admits he is not on Pfizer’s Christmas card list. Why? Because he instructs attendees how to use the FDA’s Adverse Events Reporting System to support their cases against big pharma.

Altman explains clinical trials, relative risk, the FDA approval process, and pharmaceutical adverse events. As an advocate for The Alliance for Human Research Protection, Altman considers specific drugs and drug classes in the FDA’s Medwatch database.